JP Morgan Chase’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-50,000
Closed -$2.85M – 6925
2022
Q4
$2.85M Sell
50,000
-50,000
-50% -$2.56M ﹤0.01% 3289
2022
Q3
$3.95M Sell
100,000
-29,000
-22% -$1.28M ﹤0.01% 2938
2022
Q2
$5.68M Sell
129,000
-26,400
-17% -$1.14M ﹤0.01% 2681
2022
Q1
$6.2M Buy
+155,400
New +$5.54M ﹤0.01% 2824
2021
Q2
– Sell
-30,200
Closed -$1.26M – 6440
2021
Q1
$1.26M Buy
+30,200
New +$1.38M ﹤0.01% 4063
2020
Q4
– Sell
-396,800
Closed -$10.5M – 5744
2020
Q3
$10.5M Buy
+396,800
New +$11M ﹤0.01% 2001
2019
Q3
– Sell
-75,000
Closed -$1.26M – 5823
2019
Q2
$1.26M Buy
75,000
+45,000
+150% +$726K ﹤0.01% 3698
2019
Q1
$483K Hold
30,000
– – ﹤0.01% 4222
2018
Q4
$439K Buy
+30,000
New +$479K ﹤0.01% 4198
2018
Q1
– Sell
-15,600
Closed -$316K – 5482
2017
Q4
$316K Buy
+15,600
New +$287K ﹤0.01% 4264
2016
Q3
– Sell
-144,400
Closed -$1.25M – 4644
2016
Q2
$1.25M Buy
+144,400
New +$1.42M ﹤0.01% 3069

Other funds holding HALO

JP Morgan Chase's HALO Position: Q2 2026 in Review

JP Morgan Chase reduced its Halozyme (HALO) stake by 23% in Q2 2026, selling an estimated $10.1M and leaving 485,922 shares worth $37.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

JP Morgan Chase first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. The position peaked at $239M in Q2 2021. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • JP Morgan Chase held 485,922 shares of Halozyme worth $37.9M as of Q2 2026.
  • JP Morgan Chase sold 147,808 Halozyme shares in Q2 2026, an estimated $10.1M.
  • Halozyme made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1680 holding.
  • JP Morgan Chase first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Halozyme position peaked at $239M in Q2 2021.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.